FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Ex-Dem lobbyist for company that promoted addictive opioid clears key gubernatorial hurdle

Wife of top ex-Biden advisor easily advances to House showdown in November

Cold case takes grim turn after remains identified as runaway teen; homicide investigation underway

Establishment Dem defeats socialist challenger in crucial battleground Senate primary

Incumbent GOP governor rolls to primary victory after keeping Trump at a distance

New Hampshire Senate race set between John Sununu and Chris Pappas

Nancy Pelosi Disclosed a Multi-Million Dollar AI Investment Just Weeks Before the Stock Blew Up

Turning Point Condemns Georgetown ‘Mockers and Trolls’ Planning Event for Charlie Kirk’s Death Anniversary

US Marshals Find 79 Missing and Endangered Children During Historic Operation

Netanyahu denies UAE warned him ahead of Oct. 7 as blame for massacre dominates Israeli election season

Breaking: US Responds to Failed Iran Strikes, Attacks Oil Tankers as Iran’s Economy Deteriorates

US says it destroyed five Iranian tankers after Navy warship targeted with missiles

‘Demonic’ Attack Ends in Irate Passenger Duct Taped to Seat, Thanks to Gun Guy Who Defended Jewish-Christian Author

Judge orders Alex Murdaugh murder retrial moved to nearby county

Hakeem Jeffries Facing Avalanche of Trouble from His Own Party After Midterms: ‘He’s Got a Lot of People Mad at Him’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”